Q & A: Evolution Makes Do

Evolutionary biologist Andreas Wagner argues that many evolutionary innovations may have non-adaptive origins.

Written byChris Palmer
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

SANTA FE INSTITUTE, NICOLAS RIGHETTITraits that initially confer a selective advantage often later become beneficial in some unrelated—and often surprising—way. A classic example of a so-called pre-adaptive trait, or exaptation, is the feather, which originated for a purpose other than flight. Although numerous anecdotal examples of exaptations litter the evolutionary biology literature, it is unclear how commonplace they are. Research published today (July 14) on simulated metabolic networks, however, suggests that exaptations may in fact outnumber adaptations several-fold.

“The paper is an important effort to characterize the frequency of exaptation as an evolutionary mechanism,” Richard Blob, an evolutionary biologist at Clemson University who was not involved in the study, said in an email. “The authors have identified an effective system to begin approaching this question in a systematic way.”

Leading the research was Andreas Wagner, an evolutionary biologist at the University of Zurich, who studies evolutionary innovation across many levels of biological organization, from genes to organisms to communities. Publishing in Nature with coauthor Aditya Barve, Wagner described the ubiquity of exaptations in metabolism, one of the most critical—and ancient—systems common to all multicellular organisms. To address this question, Wagner created sophisticated simulations of thousands of metabolic networks, each with a set of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo